Vanguard Fiduciary Trust
HSCS icon

Vanguard Fiduciary Trust’s Heart Test Laboratories HSCS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.3K Hold
17,239
– – ﹤0.01% 3897
2026
Q1 		$42.4K Buy
+17,239
New +$50.2K ﹤0.01% 3857

Other funds holding HSCS

TA
TFB Advisors Overland Park, Kansas $227M AUM 26.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust's HSCS Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Heart Test Laboratories (HSCS) position steady in Q2 2026 at 17,239 shares worth $43.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3897.

Vanguard Fiduciary Trust first reported a position in HSCS in Q1 2026 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

  • Vanguard Fiduciary Trust held 17,239 shares of Heart Test Laboratories worth $43.3K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Heart Test Laboratories share count unchanged in Q2 2026.
  • Heart Test Laboratories made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3897 holding.
  • Vanguard Fiduciary Trust first reported a position in Heart Test Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.